Transforming growth factor-β2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line
- 15 January 1993
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 68 (1) , 33-41
- https://doi.org/10.1016/0304-3835(93)90216-v
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1.The Journal of cell biology, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-? binding to a human colon carcinoma cell lineJournal of Cellular Physiology, 1989
- Immunodetection and quantitation of the two forms of transforming growth factor‐beta (TGF‐β1 and TGF‐β2) secreted by cells in cultureJournal of Cellular Physiology, 1989
- Modulation of C-myc by transforming growth factor-β in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1988
- Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermisNature, 1988
- Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cellsNature, 1987
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- Regulation of growth inhibitory activity in transformed mouse embryo fibroblastsExperimental Cell Research, 1987
- Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditionsBiochemical and Biophysical Research Communications, 1985